Related Experiment Video
Updated: Aug 16, 2026
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
[Clinical course and prognosis in medulloblastoma in infants and young children]
Insights
This study examined medulloblastoma in young children, finding a rapid symptom onset to admission interval and an average survival of only sixteen days post-admission. All pediatric patients succumbed to central nervous system dysregulation from the disease.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Tumor Biology
Context:
- Medulloblastoma is a malignant brain tumor affecting young children.
- Treatment outcomes for very young children with medulloblastoma are often poor.
- Münster University Clinics treated six pediatric medulloblastoma cases between 1962 and 1981.
Purpose:
- To analyze the clinical course and outcomes of young children diagnosed with medulloblastoma.
- To investigate the time intervals from symptom onset to admission and survival times in pediatric medulloblastoma patients.
Summary:
- Six children under three years old with confirmed medulloblastoma were treated.
- The average interval from symptom onset to clinical admission was six weeks.
- Average survival post-admission was sixteen days, with all patients dying due to central nervous system dysregulation.
Impact:
- Highlights the aggressive nature of medulloblastoma in very young children.
- Underscores the critical need for early diagnosis and intervention in pediatric brain tumors.
- Provides historical data on treatment outcomes for a rare pediatric malignancy.
Abstract:
From 1962 until 1981 six children with histologically assured medulloblastoma younger than three years of age have been treated at Münster University Clinics. The interval from the onset of symptoms until the clinical admission lasted six weeks, a very short time compared with the admission interval of adults. The survival time after admission was only sixteen days in average. All children died because of central disregulation due to their disease.
